GG
GordonMD Global Investments LP disclosed a 7.3% stake in KYTX
GordonMD Global Investments LP reported owning 7.3% of Kyverna Therapeutics, Inc. (KYTX) (4,521,318 shares) in a Schedule 13G filed Nov 16, 2026.
A 13G is a passive stake: the holder does not plan to push for changes.
- Disclosed
- Nov 16, 2026
- Source
- Schedule 13G